The Fully human anti-CD47 antibody SRF231 exerts dual-mechanism antitumor activity via engagement of the activating receptor CD32a

The Fully human anti-CD47 antibody SRF231 exerts dual-mechanism antitumor activity via engagement of the activating receptor CD32a

Background CD47 is a broadly expressed cell surface glycoprotein associated with immune evasion. Interaction with the inhibitory receptor signal regulatory protein alpha (SIRPα), primarily expressed on myeloid cells, normally serves to restrict effector function (eg, phagocytosis and immune cell hom...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän: Li Zhang, Emmanuel Normant, Ammar Adam, Marisa O Peluso, Caroline M Armet, Rachel W O’Connor, Benjamin H Lee, Andrew C Lake, Scott C Chappel, Jonathan A Hill, Vito J Palombella, Pamela M Holland, Alison M Paterson
Materialtyp: Artikel
Språk:English
Publicerad: BMJ Publishing Group 2020-05-01
Serie:Journal for ImmunoTherapy of Cancer
Länkar:https://jitc.bmj.com/content/8/1/e000413.full

Internet

https://jitc.bmj.com/content/8/1/e000413.full

Liknande verk